Select for export The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1301324 PubMed 17299516 Copy citation Copy BibTeX Neuropsychopharmacology 2007-02-13 Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessAnimal Study Clinical Trial More
Select for export Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuron.2007.01.008 PubMed 17270739 Copy citation Copy BibTeX Unknown journal 2007-01-31 González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyAnimal Study Animal Study More
Select for export HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2006-12-31 Veniero Gambaro, Lucia Dell’Acqua, P.F. Croci, CM Pecoraro OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyToxicity Other More
Select for export [Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine]. Abstract available at the source but not redistributed here. Read at source. Details PubMed 20143700 Copy citation Copy BibTeX Unknown journal 2006-12-31 Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A. Europe PMC Published psilocybinpsilocin Mechanism of ActionReceptor PharmacologyHealthcare Workers Other More
Select for export Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4088/jcp.v67n1110 PubMed 17196053 Copy citation Copy BibTeX The Journal of Clinical Psychiatry 2006-10-31 Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Europe PMC Published psilocybin AnxietyOCDChronic Pain Other More
Select for export Hallucinogen research inspires “neurotheology” No abstract availability was recorded for this entry. Details DOI 10.1016/s1474-4422(06)70541-5 Copy citation Copy BibTeX The Lancet Neurology 2006-08-17 Kelly Morris OpenAlex Published psilocybin Receptor PharmacologyMystical Experience Other More
Select for export Hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1542/pir.27.8.314 Copy citation Copy BibTeX Pediatrics in Review 2006-07-31 David L. Eldridge, Karin Hillenbrand OpenAlex Published psilocybin AnxietyAddictionEnd-of-Life Distress Case Report More
Select for export Effects of psilocybin on time perception and temporal control of behaviour in humans. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Queensland's institutional digital repository (The University of Queensland) 2006-05-18 Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P Europe PMC Published psilocybin Receptor PharmacologyConsciousnessDrug Interactions Other More
Select for export Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2006-931576 PubMed 16673333 Copy citation Copy BibTeX Planta Medica 2006-04-27 Jensen N, Gartz J, Laatsch H. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A Receptor Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.20.4.a247-c Copy citation Copy BibTeX The FASEB Journal 2006-02-28 M. Braden, James J. Chambers, David E. Nichols OpenAlex Published psilocin PharmacologyReceptor PharmacologyDrug Interactions Other More
Select for export Psilocin multiple intake resulted and in cardiotoxic effects No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Acta Toxicologica 2005-12-31 Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Sławomir Majdanik, Piotr Waloszczyk, Małgorzata Piasecka, Tomasz Janus OpenAlex Published psilocin PharmacologyReceptor Pharmacology Other More
Select for export SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/chin.200602219 Copy citation Copy BibTeX ChemInform 2005-12-12 Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-916185 PubMed 16342002 Copy citation Copy BibTeX Pharmacopsychiatry 2005-10-31 Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M Europe PMC Published psilocybin Receptor PharmacologyHealthy Volunteers Other More
Select for export Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1162/089892905774597191 PubMed 16269092 Copy citation Copy BibTeX Journal of Cognitive Neuroscience 2005-09-30 Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyDrug Interactions Other More
Select for export SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bmcl.2005.06.104 PubMed 16061378 Copy citation Copy BibTeX Bioorganic & Medicinal Chemistry Letters 2005-09-30 Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P Europe PMC Published psilocybinpsilocin OCDReceptor PharmacologyAnimal Study Animal Study More
Select for export Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-918695 Copy citation Copy BibTeX Pharmacopsychiatry 2005-08-31 Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1300621 PubMed 15688092 Copy citation Copy BibTeX Unknown journal 2005-05-31 Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D Europe PMC Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export P.3.027 Mismatch negativity generation in the human serotonergic and antiglutamatergic model of psychosis No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(05)80963-0 Copy citation Copy BibTeX European Neuropsychopharmacology 2004-12-31 Authors unavailable OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Development of a psilocin immunoassay for serum and blood samples. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00414-004-0469-9 PubMed 15526212 Copy citation Copy BibTeX Unknown journal 2004-08-02 Albers C, Köhler H, Lehr M, Brinkmann B, Beike J. Europe PMC Published psilocybinpsilocin AddictionReceptor Pharmacology Other More
Select for export Psilocybin impairs high-level but not low-level motion perception. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/00001756-200408260-00023 PubMed 15305143 Copy citation Copy BibTeX Unknown journal 2004-07-31 Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX. Europe PMC Published psilocybin Receptor Pharmacology Other More
